Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2022;10(12):26 Sci Rep. 2018 11-Apr;():. 10.1038/s41598-018-26656-2What this means for my practice?
While under the influence of psilocybin, participants were less likely to reject unfair offers, indicating that psilocybin has an effect on social decision making. Larger, randomized trials are needed in order to further evaluate these results. In the random generated version of the game, the median no drug rejection rate was 32.85% (IQR 0.69, 93.15), while after psilocybin the median rejection rate was 0% (IQR 0, 38.2).
Study Summary
This paper presented two studies, one of which is described in this report. The study on psilocybin included 23 male participants in a within-subject design, in which either a 2 mg intravenous dose was given, or no drug was given. The Ultimatum Game was played and the rejection rates of unfair offers were analyzed. It was found that psilocybin reduced the rejection of unfair offers, potentially meaning there is an alteration in the conceptualization of social rewards after a dose of psilocybin.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!